Cargando…
Prognostic Significance of Promoter DNA Hypermethylation of cysteine dioxygenase 1 (CDO1) Gene in Primary Breast Cancer
Using pharmacological unmasking microarray, we identified promoter DNA methylation of cysteine dioxygenase 1 (CDO1) gene in human cancer. In this study, we assessed the clinicopathological significance of CDO1 methylation in primary breast cancer (BC) with no prior chemotherapy. The CDO1 DNA methyla...
Autores principales: | Minatani, Naoko, Waraya, Mina, Yamashita, Keishi, Kikuchi, Mariko, Ushiku, Hideki, Kojo, Ken, Ema, Akira, Nishimiya, Hiroshi, Kosaka, Yoshimasa, Katoh, Hiroshi, Sengoku, Norihiko, Tanino, Hirokazu, Sidransky, David, Watanabe, Masahiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4718689/ https://www.ncbi.nlm.nih.gov/pubmed/26785325 http://dx.doi.org/10.1371/journal.pone.0144862 |
Ejemplares similares
-
Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical role in phenylbutyrate treatment-resistant breast cancer
por: Kikuchi, Mariko, et al.
Publicado: (2015) -
Diagnostic potential of hypermethylation of the cysteine dioxygenase 1 gene (CDO1) promoter DNA in pancreatic cancer
por: Nishizawa, Nobuyuki, et al.
Publicado: (2019) -
Phase II randomized, controlled trial of 1 day versus 3 days of dexamethasone combined with palonosetron and aprepitant to prevent nausea and vomiting in Japanese breast cancer patients receiving anthracycline-based chemotherapy
por: Kosaka, Yoshimasa, et al.
Publicado: (2015) -
Historical progress of the 8th edition of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual in patients with breast cancer
por: Kosaka, Yoshimasa, et al.
Publicado: (2019) -
BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
por: Tanino, Hirokazu, et al.
Publicado: (2016)